MyFinsight
Home
Blog
About
Inventory
$2,384,300K
(4.84%↑ Y/Y)
Accounts receivable, net
of allowance for...
$1,885,600K
(16.09%↑ Y/Y)
Cash and cash
equivalents
$1,285,000K
(-53.42%↓ Y/Y)
Other current assets
$1,238,000K
(45.54%↑ Y/Y)
Accounts receivable, net
of allowance for...
$512,800K
(11.53%↑ Y/Y)
Intangible assets, net
$13,516,400K
(42.77%↑ Y/Y)
Total current assets
$7,305,700K
(-8.31%↓ Y/Y)
Goodwill
$6,990,800K
(7.67%↑ Y/Y)
Property, plant and
equipment, net
$2,994,100K
(-3.38%↓ Y/Y)
Investments and other assets
$831,800K
(30.44%↑ Y/Y)
Operating lease assets
$245,700K
(-26.55%↓ Y/Y)
Deferred tax asset
$202,100K
(-38.92%↓ Y/Y)
Total assets
$32,086,600K
(13.26%↑ Y/Y)
Total liabilities and
equity
$32,086,600K
(13.26%↑ Y/Y)
Total equity
$18,848,000K
(6.88%↑ Y/Y)
Total liabilities
$13,238,600K
(23.77%↑ Y/Y)
Treasury stock, at cost
$2,977,100K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income (loss)
-$127,700K
(46.37%↑ Y/Y)
Retained earnings
$20,969,700K
(4.15%↑ Y/Y)
Notes payable and term
loan
$7,290,300K
(16.02%↑ Y/Y)
Total current
liabilities
$3,917,100K
(23.04%↑ Y/Y)
Deferred tax liability
$945,500K
(699.24%↑ Y/Y)
Other long-term
liabilities
$820,900K
(2.66%↑ Y/Y)
Long-term operating lease
liabilities
$264,800K
(-14.83%↓ Y/Y)
Additional paid-in capital
$983,000K
(37.68%↑ Y/Y)
Common stock, par value
0.0005 per share
$100K
(0.00%↑ Y/Y)
Accrued expense and
other
$2,626,300K
(-1.29%↓ Y/Y)
Current portion of term
loan
$800,000K
Accounts payable
$403,900K
(-1.10%↓ Y/Y)
Taxes payable
$86,900K
(-24.30%↓ Y/Y)
Back
Back
Balance Sheet
Biogen-svg
source: myfinsight.com
BIOGEN INC. (BIIB)
Biogen-svg
BIOGEN INC. (BIIB)